Success Stories: EB-1A Approved for Research Associate in Texas in the Field of Cardiology
Client’s Testimonial:
Thanks for the great news. Such a wonderful team you have. I am very happy that I choose your team for such an important step in my carrier. I deeply appreciate your support and help.
Position at the Time of Case Filing: Research Associate
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Texas
Approval Notice Date: July 11, 2014
Processing Time: 4 months, 27 days
In this case, the client that we had the opportunity to work with was a Research Associate from India in the field of Cardiology. He had conducted his research in the highly specialized areas of the genetic and molecular mechanisms in heart failure and myocardial remodeling. His work had resulted in at least 27 peer-reviewed scientific articles, numerous presentations and invited talks at national and international conferences, at least 1 patent and at least 1 book chapter; at the time that his case was filed, his publications had been cited at least 670 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 38 manuscripts for distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “where [Client] has flourished is in being the first scientist to comprehensively investigate whether or not RAS produces ANG II within the cells like it does externally. RAS activates during pathological conditions related to the heart, and ANG II has long been indicated to agitate cardiac disorders because of how its presence constricts the blood vessels. Treatments for these disorders have been targeted at ANG II, but they still have not shown the desired effects because they were suspected to only target extracellular expressions of it. [Client] managed to prove through his research that ANG II was synthesized within the cells through extensive testing and experimentation, and discovered how this synthesis actually took place.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Cardiology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 4 months and 27 days.